PROCEPT BioRobotics Corporation Stock
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.08 USD | -1.60% | +8.07% | +62.46% |
Financials (USD)
Sales 2024 * | 214M | Sales 2025 * | 300M | Capitalization | 3.5B |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -76M | EV / Sales 2024 * | 16.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.7 x |
P/E ratio 2024 * |
-35.2
x | P/E ratio 2025 * |
-46.8
x | Employees | 626 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.95% |
Latest transcript on PROCEPT BioRobotics Corporation
1 day | -1.60% | ||
1 week | +8.07% | ||
Current month | +28.51% | ||
1 month | +30.96% | ||
3 months | +36.25% | ||
6 months | +103.36% | ||
Current year | +62.46% |
Managers | Title | Age | Since |
---|---|---|---|
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Kevin Waters
DFI | Director of Finance/CFO | 46 | - |
Barry Templin
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frederic Moll
CHM | Chairman | 72 | 11-07-31 |
Taylor Harris
BRD | Director/Board Member | 48 | 20-12-16 |
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.60% | 14 M€ | -2.11% | ||
0.05% | 234 M€ | +6.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 68.14 | -1.52% | 445,284 |
24-05-15 | 69.19 | +5.94% | 994,812 |
24-05-14 | 65.31 | +2.85% | 497,673 |
24-05-13 | 63.5 | +1.36% | 453,652 |
24-05-10 | 62.65 | -0.56% | 411,490 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.46% | 3.56B | |
-4.72% | 182B | |
+3.96% | 112B | |
-2.93% | 68.58B | |
+6.30% | 51.58B | |
+8.02% | 44.24B | |
+8.20% | 43.65B | |
+26.18% | 32.46B | |
+16.53% | 25.99B | |
+0.57% | 25.61B |
- Stock Market
- Equities
- PRCT Stock